Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Friday, Feb. 21, 2014, 123 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $98.40 to $9,872,759.00. Highlighted Stocks Traded by Insiders: Janus Capital Group (JNS) - FREE Research Report Fredericks J Richard who is Director at Janus Capital Group bought 5,000 shares at $10.69 on Feb. 21, 2014. Following this transaction, the Director owned 12,674 shares meaning that the stake was reduced by 65.16% with the 5,000-share transaction. The shares most recently traded at $11.34, up $0.65, or 5.73% since the insider transaction. Historical insider transactions for Janus Capital Group go as follows:
- 4-Week # shares bought: 26,000
- 12-Week # shares bought: 26,000
- 24-Week # shares bought: 26,000
Mednax (MD) - FREE Research Report Andreano Dominic J who is SVP, General Counsel and Secy at Mednax sold 3,000 shares at $61.00 on Feb. 21, 2014. Following this transaction, the SVP, General Counsel and Secy owned 16,135 shares meaning that the stake was reduced by 15.68% with the 3,000-share transaction. The shares most recently traded at $60.79, down $0.21, or 0.35% since the insider transaction. Historical insider transactions for Mednax go as follows:
- 4-Week # shares sold: 9,200
- 12-Week # shares sold: 9,200
- 24-Week # shares sold: 10,695
Cavium (CAVM) - FREE Research Report Ali Syed who is Pres., CEO, Chairman of board at Cavium sold 100,000 shares at $40.17 on Feb. 21, 2014. Following this transaction, the Pres., CEO, Chairman of board owned 1.3 million shares meaning that the stake was reduced by 7.3% with the 100,000-share transaction. Pangrazio Vincent P who is SVP,Gen. Counsel & Secretary at Cavium sold 1,500 shares at $40.00 on Feb. 21, 2014. Following this transaction, the SVP,Gen. Counsel & Secretary owned 9,800 shares meaning that the stake was reduced by 13.27% with the 1,500-share transaction. The shares most recently traded at $40.58, up $0.58, or 1.43% since the insider transaction. Historical insider transactions for Cavium go as follows:
- 4-Week # shares sold: 100,000
- 12-Week # shares sold: 100,000
- 24-Week # shares sold: 100,000